The Weight Loss Breakthrough Everyone Is Talking About: GLP-1 and GIP Explained
- EvergreenMedicalClinic
- Jul 20
- 6 min read
If you've ever felt frustrated that diet and exercise alone aren't delivering lasting results, you're not alone. Scientists now understand that weight is influenced by complex biological signals and not just willpower. Two hormones, GLP-1 and GIP, are transforming how we treat obesity by helping regulate hunger, fullness, blood sugar, and energy balance. Here's why these hormones are changing the future of medical weight management.
For many years, people believed that losing weight was simply a matter of eating less and exercising more. While healthy eating and regular physical activity remain the foundation of good health, modern research has shown that body weight is regulated by a complex network of hormones, brain signals, genetics, and metabolism.
This is why many people find it difficult to lose weight or keep it off or even when they are making healthy lifestyle changes.
One of the biggest breakthroughs in obesity medicine has been the discovery of two naturally occurring hormones: GLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-Dependent Insulinotropic Polypeptide). These hormones play a central role in regulating appetite, blood sugar, and energy balance. Medications that mimic their actions are changing the way doctors approach weight management.Weight gain is not simply about eating too much.
Many people struggle with:
Hormonal imbalances
Insulin resistance
Increased hunger hormones
Slower metabolism
Difficulty feeling full after meals
These biological factors make long-term weight loss challenging.
GLP-1 and GIP medications target these underlying mechanisms rather than relying on willpower alone.
Weight Is More Than Just Willpower
If you've ever felt hungry shortly after eating or found yourself craving food despite your best efforts, it doesn't necessarily mean you lack discipline.
Your body is designed to protect its energy stores. When you lose weight, your brain may respond by increasing hunger signals and reducing the number of calories your body burns. This is one reason why maintaining weight loss can be so challenging.
Other biological factors can also contribute to weight gain, including:
Insulin resistance
Hormonal changes
Poor sleep
Chronic stress
Certain medications
Genetics
Menopause or age-related metabolic changes
Understanding these factors helps explain why obesity is now recognised as a chronic, relapsing medical condition, rather than simply a lifestyle issue.
Which Medication Uses GLP-1?
Examples include:
Semaglutide
Liraglutide
These medications mimic GLP-1 and are widely used to support weight management and blood sugar control.
Which Medication Uses Both GLP-1 and GIP?
One newer option combines both hormone pathways:
Tirzepatide (Mounjaro)
This medication activates both GLP-1 and GIP receptors, helping many patients achieve greater weight loss compared with GLP-1-only treatments in clinical studies.
Which Treatment Helps You Lose More Weight?
Clinical research has shown that dual GIP/GLP-1 therapies can produce greater average weight loss than GLP-1-only therapies for many patients, although individual results vary.
Your results depend on factors such as:
Starting weight
Medical history
Diet
Physical activity
Sleep
Stress
Adherence to treatment
There is no single "best" medication for everyone. A personalised medical assessment is important to determine the most appropriate option.
How GLP-1 Works
GLP-1 is a hormone released by your intestines after you eat. It sends signals throughout the body that help regulate appetite and blood sugar.
Its effects include:
1. It Reduces Hunger
GLP-1 acts on areas of the brain involved in appetite control, helping reduce hunger and cravings. Many people naturally feel satisfied with smaller portions.
2. It Slows Stomach Emptying
Food remains in the stomach longer, prolonging feelings of fullness after meals. This can reduce snacking and overeating.
3. It Improves Blood Sugar Control
GLP-1 stimulates insulin release when blood glucose levels rise and suppresses glucagon, a hormone that raises blood sugar. This helps maintain healthier glucose levels after eating.
4. It Supports Long-Term Weight Management
By addressing appetite regulation rather than relying solely on willpower, GLP-1 can help many people sustain healthier eating patterns over time.
What Does GIP Do?
GIP is another hormone released after meals. It was initially recognised for its role in stimulating insulin release, but researchers have since discovered that it has broader effects.
GIP may:
Enhance insulin secretion in response to food
Work alongside GLP-1 to improve blood sugar control
Influence fat metabolism
Help regulate appetite when combined with GLP-1
Contribute to overall metabolic health
While GIP alone is not typically used for weight management, combining it with GLP-1 has shown greater benefits than targeting GLP-1 alone in many patients.
Why Do GLP-1 and GIP Work Better Together?
Think of weight regulation as a complex communication system involving the brain, digestive tract, pancreas, liver, and fat tissue.
GLP-1 and GIP each influence different parts of this system. When both pathways are activated, they can complement one another by:
Enhancing feelings of fullness
Improving blood sugar regulation
Supporting healthier eating habits
Reducing appetite more effectively than GLP-1 alone in some individuals
Improving overall metabolic function
This is why dual receptor medications have become an important advancement in obesity treatment.
They're Treating Biology and Not Just Calories
One of the biggest misconceptions about weight loss is that success depends only on calorie counting.
In reality, your body continuously regulates:
Hunger
Satiety (feeling full)
Blood sugar
Energy expenditure
Hormone levels
Fat storage
GLP-1 and GIP-based therapies help address these biological processes. Rather than simply telling people to "eat less," they work by changing how the body regulates appetite and metabolism.
This biological approach can make it easier for appropriate patients to adopt and maintain healthier eating habits. Who May Benefit from GLP-1 or GIP-Based Treatment?
You may be a candidate if you:
Have a BMI of 27 or above with weight-related health conditions
Have obesity
Have prediabetes or type 2 diabetes
Experience insulin resistance
Have fatty liver disease
Have struggled to lose weight through diet and exercise alone
A healthcare professional can determine whether these treatments are suitable based on your overall health and medical history.
What Are the Common Side Effects?
Most side effects are mild and improve as your body adjusts.
Common side effects include:
Nausea
Constipation
Diarrhoea
Reduced appetite
Bloating
Fullness after meals
Your healthcare provider can advise on strategies to minimise side effects, such as gradual dose escalation and dietary adjustments.
The Future of Weight Management
Medical weight management is evolving rapidly.
Researchers are developing therapies that not only reduce appetite but also aim to:
Improve metabolic health
Better preserve lean muscle mass during weight loss
Reduce the risk of obesity-related conditions
Support long-term weight maintenance
Emerging treatments, including investigational medications that target multiple hormone pathways, may further expand the options available in the future.
Frequently Asked Questions
If GLP-1 and GIP reduce appetite, do I still need to eat healthily?
Yes. These medications can make it easier to eat appropriate portions, but nutritious food choices remain essential for overall health and maintaining weight loss.
Will I stop feeling hungry completely?
No. The goal is not to eliminate hunger, but to restore more balanced appetite signals so you feel satisfied after eating an appropriate amount.
Are these medications suitable for everyone?
No. They are prescription treatments that require a medical assessment to determine whether they are appropriate based on your health status, medical history, and treatment goals.
Key Takeaway
GLP-1 and GIP are effective because they work with the body's natural biology rather than against it. By helping regulate appetite, fullness, insulin response, and metabolism, they address some of the underlying mechanisms that contribute to obesity and excess weight.
For people who have struggled to achieve lasting results through lifestyle changes alone, these therapies may provide an evidence-based option when prescribed and monitored by a qualified healthcare professional. Combined with healthy habits and ongoing support, they can play an important role in a personalised, long-term approach to weight management.
Book Online Today: https://booky.my/evergreenmedicalclinic
Get in Touch With Us
Contact: +6018-9698786
References
Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022.
Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021.
Nauck MA, Meier JJ. Incretin hormones: Their role in health and disease. Diabetes, Obesity and Metabolism. 2018.
Holst JJ. The Physiology of Glucagon-like Peptide 1. Physiological Reviews. 2007.
Garvey WT, et al. Medical Care of Patients with Obesity: Clinical Practice Guidelines. Endocrine Practice. 2016.
Comments